Cannabidiol Supplements Market

Cannabidiol Supplements Market - Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029

Cannabidiol Supplements Market Segmented By Product Type such as Food and beverages, Medicines and therapeutics, Skincare products with Application such as Epilepsy, Multiple sclerosis, Bipolar disorder, Schizophrenia, Parkinson disease

Report ID: PMRREP30205

Report Type: Ongoing

Format: PPT*, PDF, EXCEL

Industry: Healthcare

Report Price

$4900*

Pre Book

Market Overview

Cannabidiol are obtained from hemp plant and are known for their antipsychotic properties. Cannabidiol are widely used in the treatment of neuropsychiatric disorders such as epilepsy, schizophrenia, etc. Cannabinoids are also used in treating anxiety, insomnia, and depression. There is an increasing demand of cannabidiol globally due to its several benefits and applications.

Cannabidiol are used in cosmetics, food and beverages, and therapeutic medicines. Market players are trying to expand the therapeutic application of cannabidiol thus creating more opportunity and scope for the growth of the cannabidiol supplements market in the future. Epidiolex is the first FDA approved cannabidiol drug in the market.

Rising prevalence of diseases like epilepsy, schizophrenia are the major factors driving growth of the cannabidiol supplements market. Increasing use of cannabidiol in skincare products is further anticipated to surge the growth of the cannabidiol supplements market.

The cosmetics skincare products infused with cannabidiol improves anti-aging properties of the cosmetics and helps in natural healing of skin. Growing demand of cannabidiol in pharmaceutical products is supporting the growth of the cannabidiol supplements market. Increasing legalization of cannabidiol for medicinal use is further expected to aid in the growth of the cannabidiol supplements market. The increasing demand of cannabidiol in food and beverages industries as a supplement is further aiding the cannabidiol supplements market growth.

Intensive research and development activities to expand the therapeutic applications of cannabidiol is anticipated to support the growth of the cannabidiol supplements market. The presence of huge number of market players are further anticipated to boost the growth of the cannabidiol supplements market. However there are several side-effects associated with the usage of cannabidiol such as diarrhea, headaches, fatigue etc., which in turn hamper the growth of the cannabidiol supplements market.

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get Report Sample

Market Segmentation

Based on Product Type
  • Food and beverages
  • Medicines and therapeutics
  • Skincare products
  • others
Based on Application
  • Epilepsy
  • Multiple sclerosis
  • Bipolar disorder
  • Schizophrenia
  • Parkinson disease
  • Others
Based on Form
  • Capsules
  • Oil
  • Aerosol spray
  • Edibles
  • Tinctures
  • Vape and smoke
  • Topicals
  • Others
Based on Distribution Channel
  • Hospital pharmacies
  • Retail pharmacy
  • Drug stores
  • online
Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Regional Outlook

The North America is accounted for significant market share in terms of revenue and is expected to dominate the cannabidiol supplements market over the forecast period. This is attributed to the rising prevalence of epilepsy and schizophrenia patient. Also, intensive research and development activities is further aiding in the growth of the cannabidiol supplements market.

Furthermore FDA approval of cannabidiols are further assisting the growth of the cannabidiol supplements market.  Europe is accounted for second most lucrative region due to higher adoption of cannabidiol medication. Also improved healthcare facilities and FDA approval of several cannabidiol medicines in the region is further expected to drive the growth of the cannabidiol supplements market in the region.

The Asia Pacific is expected to register prominent growth in the near future, owing to the increasing patients of schizophrenia and rising awareness of people towards benefits of cannabidiol. The higher disposable income of the people and increasing healthcare per capita is also contributing to the cannabidiol supplements market growth.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Key Players

The major key players operating in the cannabidiol supplements market are Greenwich Biosciences, Inc., Endoca, C V Sciences, Isodiol International, Global cannabinoids, Folium Biosciences, HempMeds, Stock CBD supplements, Medical Marijuana, Inc, Elixinol, and Pharmahemp D.o.o.

The report covers exhaustive analysis on:

  • Cannabidiol supplements market Segments
  • Cannabidiol supplements market Dynamics
  • Historical Actual Market Size, 2013 - 2017
  • Cannabidiol supplements market Size & Forecast 2018 to 2024
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

For report customisation and delivery information contact our sales representative.

Companies Covered in This Report

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate